These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 3034649

  • 1. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG, Meijer C, Timmer-Bosscha H, Le TK, de Vries EG, Mulder NH.
    Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
    [No Abstract] [Full Text] [Related]

  • 2. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
    Kimura I, Ohnoshi T, Hiraki S, Miyamoto H.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):830-6. PubMed ID: 3032107
    [Abstract] [Full Text] [Related]

  • 3. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
    Györffy B, Serra V, Jürchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schäfer R.
    Oncogene; 2005 Nov 17; 24(51):7542-51. PubMed ID: 16044152
    [Abstract] [Full Text] [Related]

  • 4. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
    Povarov LS, Leont'eva OV, Bernaki PD, Olsuf'eva EN, Salimova EI, Pera P, Preobrazhenskaia MN.
    Bioorg Khim; 1995 Dec 17; 21(12):925-32. PubMed ID: 8602889
    [Abstract] [Full Text] [Related]

  • 5. Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.
    Arcamone F.
    Cancer Res; 1985 Dec 17; 45(12 Pt 1):5995-9. PubMed ID: 3864526
    [Abstract] [Full Text] [Related]

  • 6. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
    Kanter PM, Schwartz HS.
    Cancer Res; 1979 Sep 17; 39(9):3661-72. PubMed ID: 476691
    [Abstract] [Full Text] [Related]

  • 7. In vitro studies on anthracycline haloderivatives.
    Facchinetti T, Geroni C, Fumagalli A, Giuliani FC.
    Drugs Exp Clin Res; 1986 Sep 17; 12(8):657-61. PubMed ID: 3463498
    [Abstract] [Full Text] [Related]

  • 8. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
    Chandrasekaran B, Dimling J, Capizzi RL.
    Cancer Treat Rep; 1987 Feb 17; 71(2):195-6. PubMed ID: 2948640
    [Abstract] [Full Text] [Related]

  • 9. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW, Raymond V.
    Cancer Treat Rep; 1986 Jan 17; 70(1):51-63. PubMed ID: 2935251
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Doxorubicin, daunorubicin, and mitoxantrone cytotoxicity in yeast.
    Kule C, Ondrejickova O, Verner K.
    Mol Pharmacol; 1994 Dec 17; 46(6):1234-40. PubMed ID: 7808447
    [Abstract] [Full Text] [Related]

  • 12. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan 17; 20(1):12-8. PubMed ID: 6173340
    [Abstract] [Full Text] [Related]

  • 13. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N.
    Gan To Kagaku Ryoho; 1984 Dec 17; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [Abstract] [Full Text] [Related]

  • 14. [Cytotoxic effect of topoisomerase II inhibitors against adriamycin- and etoposide-resistant small cell lung cancer sublines].
    Takigawa N, Ohnoshi T, Ueoka H, Yonei T, Kiura K, Tabata M, Kodani T, Kamei H, Segawa Y, Shibayama T.
    Gan To Kagaku Ryoho; 1993 May 17; 20(7):929-35. PubMed ID: 8387762
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
    Horton D, Khare A.
    Bioorg Med Chem Lett; 2010 Nov 01; 20(21):6179-81. PubMed ID: 20850305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M, Oszczapowicz I, Wietrzyk J, Opolski A, Madej J, Dzimira S, Oszczapowicz J.
    Anticancer Res; 2005 Nov 01; 25(3B):2043-8. PubMed ID: 16158943
    [Abstract] [Full Text] [Related]

  • 18. Enhanced sensitivity of the rat hepatoma cell to the daunorubicin analogue 4-demethoxydaunorubicin associated with induction of DNA damage.
    Woods KE, Ellis AL, Randolph JK, Gewirtz DA.
    Cancer Res; 1989 Sep 01; 49(17):4846-51. PubMed ID: 2758416
    [Abstract] [Full Text] [Related]

  • 19. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
    Hindenburg AA, Baker MA, Gleyzer E, Stewart VJ, Case N, Taub RN.
    Cancer Res; 1987 Mar 01; 47(5):1421-5. PubMed ID: 3469017
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
    Bogush T, Robert J.
    Anticancer Res; 1996 Mar 01; 16(1):365-8. PubMed ID: 8615637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.